as on December 6, 2025 at 2:29 am IST
Day's Low
Day's High
0.79%
Downside
5.06%
Upside
52 Week's Low
52 Week's High
53.86%
Downside
15.77%
Upside
Check Neuropace Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$554.9M
EPS (TTM)
-0.7617
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-7.76
Industry PE ratio
-0.4116938110749186
PEG Ratio
0EBITDA
-18.0M
Revenue (TTM)
94.9M
Profit Margin
-25.29%
Return On Equity TTM
-169.27%
Track how Neuropace Inc P/E has moved over time to understand its valuation trends.
Neuropace Inc in the last 5 years
Lowest (-14.90x)
March 31, 2025
Today (-7.76x)
December 5, 2025
Industry (-0.41x)
December 5, 2025
Highest (-0.38x)
December 31, 2021
Today’s Price to Earnings Ratio: -7.76x
Compare market cap, revenue, PE, and other key metrics of Neuropace Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $554.9M | NA | -7.76 | -25.29% | |
| BUY | $146.1B | 183.99% | 52.71 | 14.43% | |
| BUY | $139.9B | 52.07% | 48.09 | 12.07% | |
| BUY | $130.8B | -10.42% | 27.63 | 13.71% | |
| BUY | $218.1B | 16.22% | 15.88 | 31.88% |
The Neuropace Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Neuropace Inc investment value today
Current value as on today
₹1,51,458
Returns
₹51,458
(+51.46%)
Returns from Neuropace Inc Stock
₹45,301 (+45.3%)
Dollar Returns*
₹6,157 (+6.16%)
Based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Neuropace Inc. Average target price of $17.5
Get share price movements and forecasts by analysts on Neuropace Inc.
What analysts predicted
6.34%UPSIDE
Target Price
$17.5
Current Price
$16.39
Analyzed by
13 Analysts
Target
$17.50
Neuropace Inc target price $17.5, a slight upside of 6.34% compared to current price of $16.39. According to 13 analysts rating.
Search interest for Neuropace Inc Stock has increased by 435% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:435% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 1 month, NPCE stock has moved up by 31.4%
Best in 1 Year
![]()
In the last 1 year, NPCE has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
![]()
Revenue is up for the last 9 quarters, 16.42M → 27.35M (in $), with an average increase of 6.1% per quarter
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -8.65M → -3.49M (in $), with an average increase of 147.5% per quarter
Best in 3 Years
![]()
In the last 3 years, NPCE has outperformed top 5 stocks with highest market-cap in its industry
| Organisation | Neuropace Inc |
| Headquarters | 455 North Bernardo Avenue, Mountain View, CA, United States, 94043 |
| Industry | Healthcare |
| CEO | Mr. Joel D. Becker |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Joel D. Becker | CEO, President & Director |
Dr. Martha J. Morrell M.D. | Chief Medical Officer |
Ms. Rebecca L. Kuhn | Advisor |
Mr. Dylan St. John | Chief of Operations & Development |
Mr. Chris Reese | Senior Vice President of Sales |
Ms. Julie Hsu | VP & Controller |
Mr. Patrick F. Williams | Chief Financial Officer |
Ms. Leah Akin | General Counsel & Corporate Secretary |
Ms. Katie Keller | Vice President of Marketing |
Ms. Amy Treadwell | Vice President of Human Resources |
Neuropace Inc share price today is $16.39 as on at the close of the market. Neuropace Inc share today touched a day high of $17.22 and a low of $16.26.
Neuropace Inc share touched a 52 week high of $18.98 on and a 52 week low of $7.56 on . Neuropace Inc stock price today i.e. is closed at $16.39,which is 13.62% down from its 52 week high and 116.73% up from its 52 week low.
Neuropace Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Neuropace Inc (NPCE) shares with as little as ₹89.927 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹899.27 in Neuropace Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neuropace Inc share’s latest price of $16.39 as on December 6, 2025 at 2:29 am IST, you will get 0.6101 shares of Neuropace Inc. Learn more about
fractional shares .